The health care needs assessment (HCNA) addressed in this issue of Dermatologic Clinics is designed to aid practitioners and policy makers by providing current, evidence-based research that can be used…
Within the last few decades, outcomes research, and in particular quality of life (QoL) outcomes research, has become integrated into clinical and research practices. QoL outcomes are important to dermatology,…
Clinical meaning can be assigned to scores of health status measures by using a variety of approaches. The anchor-based approach involves determining the difference on a quality of life (QOL) scale that…
Health-related quality of life (HRQoL) is gradually becoming a standard outcome in clinical research and health care management. Nevertheless, application in dermatologic practice is not customary and many practical and…
Both congenital and acquired bullous dermatoses have the potential to impose a significant burden of disease, and the impact exerted on the quality of life (QOL) of patients is often multifaceted….
Acne vulgaris affects most adolescents and two-thirds of adults and is associated with substantial psychosocial burden. Health-related quality of life (HRQOL) for patients with acne is an important factor of…
The negative impact of psoriasis on a patient’s quality of life (QoL) is well documented in the literature. Patients often suffer poor self-esteem, difficulties in social interactions, and significant psychological distress….
The Melasma Quality of Life scale (MELASQOL) is a useful tool in assessing quality of life in patients with melasma. Initially developed in English, it has recently been translated into…
Vitiligo, an acquired disease of depigmentation, affects millions worldwide. The psychosocial and health-related quality of life (HRQL) impact of the disease varies based on several parameters, including country of origin,…
